[Polarisqb in EIN Presswire] POLARISqb and Auransa announce promising results for triple negative breast cancer using quantum computing and AI

PALO ALTO, CA, DURHAM, NC, USA, August 9, 2022 /EINPresswire.com/ — Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (Polarisqb), a quantum computing-based drug design company, announced exciting progress in a joint project to tackle triple-negative breast cancer.

Read more here.